During the past decade, Angels Clinical Research Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Angels Clinical Research Institute" are "COVID-19" (3 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Angels Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Angels Clinical Research Institute" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "PF-07321332" (3 trials), "Ritonavir" (3 trials), "Placebo" (2 trials), "Part A and B: Placebo" (1 trials) and "Part A: Upamostat 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Angels Clinical Research Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Angels Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Angels Clinical Research Institute, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Angels Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".